GenMark Files for Public Offering of 4.6M Shares

The firm expects to use proceeds to fund R&D efforts, including development of its next-generation molecular diagnostics system.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories